CLOs on the Move

UnitedHealthcare

www.uhc.com

 
At UnitedHealthcare we`re dedicated to helping people live healthier lives and helping to make the health system work better for everyone by simplifying the health care experience, meeting consumer health needs and sustaining trusted relationships with care providers. These are extraordinary times in health care. The opportunities to help people live healthier have never been greater. Advanced data and technologies, breakthrough treatments and consumer choice are redefining what can be achieved. At UnitedHealthcare, part of the UnitedHealth Group family of businesses, we are working to create a system that is connected, aligned and more affordable for all involved; one that ...
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.uhc.com
  • 9700 Health Care Lane
    Minnetonka, MN USA 55343
  • Phone: 952.222.9351

Executives

Name Title Contact Details
Jack Swift
 Chief Financial Officer - Mississippi Medicaid Profile
Alex Miskella
 Senior Associate General Counsel Profile
Laurie Wiedenhoff
 Associate General Counsel Profile
Deepa Vogel
 Associate General Counsel Profile
Jenni Khuu Katzer
 Associate General Counsel Profile

Similar Companies

AXS Studio

AXS Studio is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Genetics and IVF Institute

Genetics and IVF Institute is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Genetics and IVF Institute is based in Fairfax, VA. You can find more information on Genetics and IVF Institute at www.givf.com

Carriage Court

Carriage Court is a Marysville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ruby Valley Hospital

Ruby Valley Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Sheridan, MT. To find more information about Ruby Valley Hospital, please visit www.rubyvalleyhospital.com

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.